Stock Market Today: Major Indexes Ending Weak Quarter on High Note as Investors Optimistic Iran War May End Soon; Dow Adds 1,000 Points

Markets rallied intraday (Nasdaq +3.8%, S&P 500 +2.9%, Dow +2.5%) but still posted their worst quarter since Q2 2022: Q1 declines of Nasdaq -7.1%, S&P -4.6%, Dow -3.6%. Geopolitical risk from the Iran conflict is lifting energy prices (WTI ~$102/bbl, Brent ~$104/bbl) and gas at the pump hit $4.02/gal (AAA), while the 10-year Treasury yield slipped to <4.30% (from ~4.36% prior). Notable corporate moves: Marvell surged (~+11–13%) after a $2B Nvidia investment; Apellis agreed to a $41/sh Biogen buyout (~$5.6B) sending shares +135%; Centessa agreed to a ~$6.3B Lilly deal; McCormick/Unilever announced a ~$65B combination; Constellation guided 2026 adj operating EPS $11–$12 (midpoint below consensus) and shares fell ~6%.

Analysis

Volatility is being driven more by headline flow than by fundamentals; that makes short-term moves headline-sensitive (days) but creates differentiated opportunities over 3–12 months as real-economy pass-through (oil → CPI → wages → Fed) plays out. Energy-driven inflation risk elevates the value of real assets and revenue-linked cyclicals while compressing discretionary margins; conversely, long-duration growth assets remain sensitive to real rates more than nominal headline volatility.

Second-order winners: vendors that plug into hyperscaler AI stacks (networking, custom ASIC partners) gain durable TAM expansion even if headline pricing for DRAM and flash mean-revert; financial-market infrastructure firms benefit from sustained higher volatility and trading volumes, boosting fee pools and clearing revenue. Losers include staples/food combos undergoing integration risk where synergies are priced for perfection — deal execution and working-capital drag are the real near-term value destroyers.

Key catalysts to track: the next two monthly CPI/producer prints (4–8 weeks) for whether energy pass-through becomes persistent; DRAM/flash spot-print and cloud capex cadence over 1–3 months for tech supply-chain rehypothecation; and any diplomatic headlines that change insurance/shipping cost structure (days). Tail risks: a sudden reclosure of shipping chokepoints or a rapid, large SPR release — both would reprice energy and flush momentum trades within weeks.

Contrarian read: gold outflows look like a liquidity-driven unwind rather than conviction rotation — a measured long-gold hedge is asymmetric if real yields stop rising. Memory-stock weakness may already discount a transient spot-price pull; buyers who time around durable demand signals (enterprise AI footprint, not spot DRAM) will capture mean reversion over 6–12 months.

Key Decisions for Investors

• Buy GLD (or equivalent physical gold ETF) as a tactical hedge: entry on any pullback of 2–4% from current levels, 1–3 month holding horizon. Position size 2–4% of portfolio; target 8–12% upside if safe-haven flows resume, stop-loss at 5% — asymmetry favors insurance value vs cost of carry.
• Pair trade: long GOOGL/GOOG (core ad + AI infrastructure optionality) vs short UL (consumer/food integration risk). Use equal-dollar exposures over a 6–12 month horizon; expect 200–400bps relative outperformance if advertising/macro hold while integration headwinds hit UL. Cut pair if CPI prints accelerate >50bp above expectations.
• Event-driven: initiate small merger-arb exposure to CNTA (and selectively APLS-like targets) sized to take the deal-spread risk with 3–6 month time horizon. Hedge portfolio exposure with a biotech index short or put overlay to limit sector drawdowns; worst-case regulatory/financing pullback is primary downside.
• Tactical volatility hedge for portfolio beta: buy 1–3 month SPX put spreads or VIX call options sized to cap a 10–15% drawdown in equities. This protects against headline-driven gaps (shipping closure, major escalation) while keeping cost of carry limited compared with long-dated puts.